Skip to content
Dr. Grey AI

Supplement

Biotin (Vitamin B7)

Biotin is a B vitamin the body uses to make keratin, the protein in hair, skin and nails, and to turn food into energy. People mostly look at it for nail health, where the evidence is moderate, but the trial results available here come from progressive multiple sclerosis, where symptoms showed no clear difference. That evidence is very limited, covering four studies and 360 people, so it says little about nails.

Sources: PMID 33222767; PMID 27589059

Best evidence
Grade D
Conditions studied
3
Outcomes
3
Graded outcomes
0003

Evidence by condition

  • Strong
  • Moderate
  • Limited
  • Very limited

3 conditions

Type 2 Diabetes: outcomes studied for Biotin (Vitamin B7)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

No effect

NoneNo effect1 study33 people
Dyslipidemia: outcomes studied for Biotin (Vitamin B7)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

No effect

NoneNo effect1 study33 people

What the published studies found

1 automated reading

Automated reading of the published studies (Decosa evidence engine), for outcomes Dr. Grey has not graded yet. It is not a Dr. Grey grade and does not change one. How it is read

Key findings

  • Multiple Sclerosis SymptomsMultiple Sclerosis (MS)
  • Blood glucoseType 2 Diabetes

Shop Biotin (Vitamin B7)

Third-party tested Biotin (Vitamin B7) products. The evidence above is limited, so read it before you buy.

  • Grade D

Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure

Studies cited

7 studies from PubMed

  1. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemiaBiomed Pharmacother · PMID 16677798
  2. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialLancet Neurol · PMID 33222767
  3. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.Mult Scler · PMID 27589059
  4. High doses of biotin in chronic progressive multiple sclerosis: a pilot study.Mult Scler Relat Disord · PMID 25787192
  5. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.CNS Drugs · PMID 29808469
  6. Effects of biotin on lipids and other constituents of plasma of healthy men and womenArtery · PMID 7011260
  7. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopyJ Am Acad Dermatol · PMID 2273113